Facebook Linkedin Twitter

Phase III clinical trials (Clinical trial)

Cancer cell surrounded by therapeutic antibodies and cytokines among normal cells
News & Features

AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer and Other Solid Tumors

Malorye Branca -
0
Bladder Cancer
News & Features

Immunotherapy Added to Chemotherapy Nearly Doubles Advanced Bladder Cancer Survival

Malorye Branca -
0
Dilation and curettage (d and c).endometrial biopsy.cervical cancer.3d illustration
News & Features

Cervical Cancer Outcomes Boosted by Induction Chemotherapy

Chris Anderson -
0
Illustration showing colorectal cancer
Molecular Dx

RNA Test Outperforms the Fecal Immunochemical Test for Detection of Colorectal Cancer

Helen Albert -
0
Lung cancer, close-up, NSCLC
News & Features

NSCLC Outcomes Significantly Improved with Immunotherapy Treatments Given Before and After Surgery

Chris Anderson -
0
Vials on plate
News & Features

Harmony Acquiring Zynerba, a Leader in Development of Cannabioid-Based Gel

Malorye Branca -
0
Woman cancer patient
News & Features

Are We Nearly There Yet?

Kathy Vuksanaj -
0
antibodies
News & Features

Charging to the Frontline

Chris Anderson -
0
Lung cancer, conceptual image
News & Features

Lilly’s Retevmo Beats PD-1 Combo for RET Fusion-Positive Lung Cancer

Alisa Kirkin -
0
Lung cancer, CT
News & Features

First-line Atezolizumab Improves Survival in Platinum-Ineligible NSCLC

Chris Anderson -
0
123Page 1 of 3

Related Content

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine